Skip to main content

 

  1. Brown LB, Krysiak R, Kamanga G, et al. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis. Mar 2010;37(3):169-172.
  2. Xue J, Mhango Z, Hoffman IF, et al. Use of nutritional and water hygiene packages for diarrhoeal prevention among HIV-exposed infants in Lilongwe, Malawi: an evaluation of a pilot prevention of mother-to-child transmission post-natal care service. Trop Med Int Health. Jul 30 2010.
  3. Pettifor A, Macphail C, Corneli A, et al. Continued High Risk Sexual Behavior Following Diagnosis with Acute HIV Infection in South Africa and Malawi: Implications for Prevention. AIDS Behav. Oct 27 2010.
  4. Corbett AH, Hosseinipour MC, Nyirenda J, et al. Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children. Antivir Ther. 2010;15(1):83-90.
  5. Harries AD, Zachariah R, van Oosterhout JJ, et al. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis. Jan 2010;10(1):60-65.
  6. Nussbaum JC, Jackson A, Namarika D, et al. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Clin Infect Dis. Feb 1 2010;50(3):338-344.
  7. Hosseinipour MC, Kumwenda JJ, Weigel R, et al. Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline. HIV Med. Mar 19 2010.
  8. Robertson K, Liner J, Hakim J, et al. NeuroAIDS in Africa. J Neurovirol. May 25 2010.
  9. Hosseinipour MC, Schechter M. Monitoring Antiretroviral Therapy in Resource-Limited Settings: Balancing Clinical Care, Technology, and Human Resources. Curr HIV/AIDS Rep. May 25 2010.
  10. Jackson A, Hosseinipour MC. Management of Cryptococcal Meningitis in Sub-Saharan Africa. Curr HIV/AIDS Rep. Jun 8 2010.
  11. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. Jun 17 2010;362(24):2271-2281.
  12. Tweya H, Gareta D, Chagwera F, et al. Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the ‘Back-to-Care’ project in Lilongwe, Malawi. Trop Med Int Health. Jun 2010;15 Suppl 1:82-89.
  13. Lockman S, Hughes MD, McIntyre J, et al. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med. Oct 14 2010;363(16):1499-1509.
  14. Samuel JC, Akinkuotu A, Baloyi P, et al. Hospital-based injury data in Malawi: strategies for data collection and feasibility of trauma scoring tools. Trop Doct. Apr 2010;40(2):98-99.
  15. Chen YQ, Young A, Brown ER, et al. Population Attributable Fractions for Late Postnatal Mother-to-Child Transmission of HIV-1 in Sub-Saharan Africa. J Acquir Immune Defic Syndr. Mar 10 2010.
  16. Phiri S, Hoffman IF, Weiss HA, et al. Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi. Sex Transm Infect. May 5 2010.
  17. Hoffmann CJ, Fielding KL, Charalambous S, et al. Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa. AIDS. Jul 17 2010;24(11):1709-1716.
  18. Tang W, Harmon P, Gulley ML, et al. Viral response to chemotherapy in endemic burkitt lymphoma. Clin Cancer Res. Apr 1 2010;16(7):2055-2064.
  19. Farr SL, Nelson JA, Ng’ombe TJ, et al. Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi. J Acquir Immune Defic Syndr. Aug 15 2010;54(5):515-523.
  20. Firnhaber C, Smeaton L, Saukila N, et al. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis. Dec 2010;14(12):e1088-1092.
  21. Piwowar-Manning EM, Tustin NB, Sikateyo P, et al. Validation of rapid HIV antibody tests in 5 African countries. J Int Assoc Physicians AIDS Care (Chic). May-Jun 2010;9(3):170-172.